AzTrials
AzTrials

Premature BirthAGMANCT04770844

Development of a Developmental Prognostic Tool for the Premature Child Based on Automated Spontaneous Motor Analysis

An observational study of Premature Birth, run by Centre Hospitalier Universitaire de Saint Etienne at 1 site in France.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Prematurity is a major risk factor for poor neurodevelopmental outcomes. The clinical and neuroradiological evaluations proposed during the neonatal period to assess the developmental prognosis of children born prematurely are not sensitive and nor specific. Read more about this study

Who is it for?
Ages 1 day to 3 months
Conditions the study is for
Premature Birth
What is being tested?
Acquisitions
How many people
129 participants
Where
1 siteFrance
Study dates
23 Mar 2021to 9 Jun 2023
How long will I take part?
3 Months
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 day to 3 months
  • All sexes
  • No healthy volunteers
  • Child

Study population: children borned before 33 week of amenorrhea

Who may be able to join

  • Birth before 33 week of amenorrhea;
  • Hospitalization in the Neonatal Department of the Saint-Étienne University Hospital
  • Patient affiliated or entitled to a social security scheme;
  • Authorization to shoot the holders of parental authority;
  • Consent to participate in the study by the holders of parental authority

Who cannot join

  • Need for ventilatory support;
  • Difficulty of thermal regulation contraindicating the use of a heating cradle;
  • Refusal of authorization to shoot by holders of parental authority;
  • Refusal of participation in the study of holders of parental authority.

Trial locations and contacts

1 site in 1 country.

France1 site
  • Chu de St Etienne

    Saint-Etienne, 42000

Other trials in France

About this study

Prematurity is a major risk factor for poor neurodevelopmental outcomes. The clinical and neuroradiological evaluations proposed during the neonatal period to assess the developmental prognosis of children born prematurely are not sensitive and nor specific. The analysis of spontaneous motor activity by Prechtl's method has a better predictive value but is currently unfeasible in clinical routine. The study's principal objective is to describe the standardized values of complexity, variability, and fluidity of general movements.

Conditions
Premature Birth
Being tested
Acquisitions
Keywords
premature children, motor skill, developmental prognostic, prognostic tool
Medical subject headings
Premature Birth

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AcquisitionsOther

    Three acquisitions of 1 hours during hospitalization will be realized:

    • a few days after hospitalization,
    • in the middle of the hospitalization,
    • a few days before hospital discharge. The child will be lying on his back in a heated cradle and filmed with a specific camera. The signal will be obtained by 2k ZED 2 stereo camera in order to obtain a three-dimensional location of the child
Study groups in NCT04770844
Study groupRoleWhat they receive
premature child300 premature child will be included. They will have three acquisitions during hospitalization.
Receives: Other: Acquisitions

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Automatized quantification of complexity of general movements (spatial variation).

    Measured by analyze of all acquisitions.

    Measured: Year: 3

  2. Automatized quantification of variability of general movements (temporal variations)

    Measured by analyze of all acquisitions.

    Measured: Year: 3

  3. Automatized quantification of fluidity of general movements (uniform distribution)

    Measured by analyze of all acquisitions.

    Measured: Year: 3

Secondary outcomes (1)
  1. Comparison between our quantitative analysis and qualitative analysis according to the reference method of Pretchl

    Measured by analyze of all acquisitions.

    Measured: Year: 3

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Feb 2021
  2. Study start23 Mar 2021
  3. Primary completion24 Apr 2023
  4. Study completion9 Jun 2023

Why it stopped: inclusion difficulties

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
129 participants (actual)
Target duration
3 Months
IDs, dates and publications
ClinicalTrials.gov ID
NCT04770844
Sponsor's protocol ID
20CH234
Other IDs
2020-A03335-34
Acronym
AGMA
Status last verified
Jan 2024
First submitted
22 Feb 2021
Last updated
5 Jan 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Premature Birth, run by Centre Hospitalier Universitaire de Saint Etienne at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 5 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: inclusion difficulties). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Automatized quantification of complexity of general movements (spatial variation). (time frame: Year: 3). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jan 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in